Miscellanea. A stopping rule for the continual reassessment method
From MaRDI portal
Publication:4216701
DOI10.1093/biomet/85.3.741zbMath0918.62086OpenAlexW2118701470MaRDI QIDQ4216701
Publication date: 7 July 1999
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/85.3.741
Applications of statistics to biology and medical sciences; meta analysis (62P10) Stopping times; optimal stopping problems; gambling theory (60G40)
Related Items
A system for determining maximum tolerated dose in clinical trial ⋮ Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design ⋮ A new design of the continual reassessment method ⋮ Continual reassessment and related dose-finding designs ⋮ Adaptive Bayesian compound designs for dose finding studies ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ Dynamic calibration of pharmacokinetic parameters in dose-finding studies ⋮ Retrospective Analysis of Sequential Dose‐Finding Designs ⋮ Design efficiency in dose finding studies ⋮ Dose-Finding Designs for HIV Studies ⋮ Continual Reassessment Method for Ordered Groups ⋮ Operating characteristics of the standard phase I clinical trial design.
This page was built for publication: Miscellanea. A stopping rule for the continual reassessment method
